Literature DB >> 18467124

Expression of the extracellular region of the human interleukin-4 receptor alpha chain and interleukin-13 receptor alpha1 chain by a silkworm-baculovirus system.

Eijiro Honjo1, Yoshinari Shoyama, Taro Tamada, Hideki Shigematsu, Takaaki Hatanaka, Sachiko Kanaji, Kazuhiko Arima, Yuji Ito, Kenji Izuhara, Ryota Kuroki.   

Abstract

The receptor binding to interleukin (IL)-13 is composed of the IL-13 receptor alpha1 chain (IL-13Ralpha1) and the IL-4 receptor alpha chain (IL-4Ralpha). In order to investigate the interaction of IL-13 with IL-13Ralpha1 and IL-4Ralpha, the DNA fragments coding the extracellular regions of human IL-13Ralpha1 and the IL-4Ralpha (containing a cytokine receptor homologous region) were fused with mouse Fc and expressed by a silkworm-baculovirus system. The expressed receptors were successfully purified by affinity chromatography using protein A, and the Fc region was removed by thrombin digestion. After further purification with anion-exchange chromatography, these receptors were used to investigate the ligand-receptor interaction. Size exclusion chromatography and SPR analysis revealed that mixture of IL-13 and IL-13Ralpha1 showed predominant affinity to IL-4Ralpha, although neither detectable affinity of IL-13 nor IL-13Ralpha1 was observed against IL-4Ralpha. Combining these data with the moderate affinity of IL-13 to IL-13Ralpha1, this indicates that IL-13 first binds to IL-13Ralpha1 and recruits consequently to IL-4R.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467124     DOI: 10.1016/j.pep.2008.03.020

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

Review 1.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

2.  Distinct structural requirements for interleukin-4 (IL-4) and IL-13 binding to the shared IL-13 receptor facilitate cellular tuning of cytokine responsiveness.

Authors:  Takachika Ito; Shoichi Suzuki; Sachiko Kanaji; Hiroshi Shiraishi; Shoichiro Ohta; Kazuhiko Arima; Go Tanaka; Taro Tamada; Eijiro Honjo; K Christopher Garcia; Ryota Kuroki; Kenji Izuhara
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

3.  A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.

Authors:  Van Nguyen; Jesse M Conyers; Dongqin Zhu; Denise M Gibo; Roy R Hantgan; Steven M Larson; Waldemar Debinski; Akiva Mintz
Journal:  Neuro Oncol       Date:  2012-09-05       Impact factor: 12.300

4.  Efficient and cost effective production of active-form human PKB using silkworm larvae.

Authors:  Ryoko Maesaki; Ryosuke Satoh; Masato Taoka; Teppei Kanaba; Tsunaki Asano; Chiharu Fujita; Toshinobu Fujiwara; Yutaka Ito; Toshiaki Isobe; Toshio Hakoshima; Katsumi Maenaka; Masaki Mishima
Journal:  Sci Rep       Date:  2014-08-15       Impact factor: 4.379

5.  A real-time PCR-based quantitative assay for 3-methylcytosine demethylase activity of ALKBH3.

Authors:  Yuko Ueda; Kaori Kitae; Ikumi Ooshio; Yasuyuki Fusamae; Megumi Kawaguchi; Kentaro Jingushi; Kazuo Harada; Kazumasa Hirata; Kazutake Tsujikawa
Journal:  Biochem Biophys Rep       Date:  2016-02-10

Review 6.  Silkworm expression system as a platform technology in life science.

Authors:  Tatsuya Kato; Mizuho Kajikawa; Katsumi Maenaka; Enoch Y Park
Journal:  Appl Microbiol Biotechnol       Date:  2010-01       Impact factor: 4.813

7.  Nonviral production of human interleukin-7 in spodoptera frugiperda insect cells as a soluble recombinant protein.

Authors:  Maryam Mirzaei; Yan Xu; Cynthia B Elias; Satya Prakash
Journal:  J Biomed Biotechnol       Date:  2008-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.